FDA Approves Taletrectinib for ROS1-Positive NSCLC – Full Details Lung Cancer Treatment 3 Mins Read On June 11, 2025, the U.S. Food and Drug Administration (FDA) approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a new kinase…
